

Author: Frampton James E.
Publisher: Adis International
ISSN: 1173-8804
Source: BioDrugs, Vol.26, Iss.2, 2012-04, pp. : 121-123
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa™)†
BioDrugs, Vol. 24, Iss. 5, 2010-10 ,pp. :








Ecallantide in Acute Hereditary Angioedema†: Profile Report
BioDrugs, Vol. 25, Iss. 1, 2011-02 ,pp. :